Antigenic changes in influenza A(H3N2) driven by genetic evolution: Insights from virological surveillance, EU/EEA, week 40/2023 to week 9/2024
2024

Influenza A(H3N2) Changes in Europe: 2023/24 Season Insights

Sample size: 154718 publication 10 minutes Evidence: moderate

Author Information

Author(s): Eeva K Broberg, Maja Vukovikj, Olov Svartström, Iris Hasibra, Maximilian Riess, Angeliki Melidou

Primary Institution: European Centre for Disease Prevention and Control (ECDC)

Hypothesis

How do the circulating influenza viruses in the EU/EEA during the 2023/24 season compare to the vaccine components?

Conclusion

The 2023/24 influenza season showed co-circulation of various influenza types, with significant genetic diversification observed in A(H3N2) viruses.

Supporting Evidence

  • 154,718 influenza virus detections were reported during the study period.
  • 97% of detections were type A viruses.
  • 23% of A(H3N2) viruses were antigenically distinct from the vaccine strain.

Takeaway

This study looked at the flu viruses in Europe and found that while some matched the vaccine, others, especially A(H3N2), did not.

Methodology

Surveillance data were collected from EU/EEA countries through weekly submissions to The European Surveillance System (TESSy) for weeks 40/2023 to 9/2024.

Potential Biases

Potential bias in virus selection for characterisation and reporting inconsistencies across countries.

Limitations

Only a small percentage of detected viruses were characterised, and the selection processes for characterisation varied by country.

Participant Demographics

Data collected from 29 EU/EEA countries.

Statistical Information

Confidence Interval

95% CI: 41–63

Digital Object Identifier (DOI)

10.2807/1560-7917.ES.2024.29.50.2400395

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication